Volume 100, Issue 8

Search all Annals of Hematology articles

August 2021

32 articles in this issue

Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia
Jéssica V. G. F. Batista
Diego A. Pereira-Martins
Marcos A. Bezerra
Original Article 14 June 2021 Pages: 1921 - 1927
Extracellular vesicles from thalassemia patients carry iron-containing ferritin and hemichrome that promote cardiac cell proliferation
Anyapat Atipimonpat
Panjaree Siwaponanan
Kovit Pattanapanyasat
Original Article 21 June 2021 Pages: 1929 - 1946
Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study
Stinne Tranekær
Dennis Lund Hansen
Henrik Frederiksen
Original Article 16 June 2021 Pages: 1947 - 1951
δ-Hemoglobinopathies in Thailand: screening, molecular basis, genotype-phenotype interaction, and implication for prevention and control of thalassemia
Kritsada Singha
Goonnapa Fucharoen
Supan Fucharoen
Original Article 08 April 2021 Pages: 1953 - 1963
Diagnosis and management of non-clonal erythrocytosis remains challenging: a single centre clinical experience
Saša Anžej Doma
Eva Drnovšek
Irena Preložnik Zupan
Original Article Open access 19 May 2021 Pages: 1965 - 1973
The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure
Kohei Hosokawa
Ken Ishiyama
Shinji Nakao
Original Article 23 October 2020 Pages: 1975 - 1982
Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome—excess blasts detected by next-generation sequencing technique
Weerapat Owattanapanich
Julia Herzig
Konstanze Döhner
Original Article Open access 10 April 2021 Pages: 1983 - 1993
Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients
Kamila Janusz
Marta Martín Izquierdo
María Díez Campelo
Original Article 06 January 2021 Pages: 1995 - 2004
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib
Giovanni Caocci
Olga Mulas
Giorgio La Nasa
Original Article 03 January 2021 Pages: 2005 - 2014
Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms
Karlo Huenerbein
Parvis Sadjadian
Kai Wille
Original Article Open access 20 November 2020 Pages: 2015 - 2022
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1^T315I and BCR-ABL1^T315I-E255K
Afsar Ali Mian
Isabella Haberbosch
Jamal Mahajna
Original Article Open access 10 June 2021 Pages: 2023 - 2029
Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort
Harpreet Virk
Sonia Rana
Sreejesh Sreedharanunni
Original Article 22 June 2021 Pages: 2031 - 2041
Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry
Heiner Zimmermann
Mirko Nitsche
for the German PTLD Study Group and German Lymphoma Alliance
Original Article 11 May 2021 Pages: 2043 - 2050
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial
Ji Hyun Lee
Yong Park
the Korean multiple myeloma working party [KMMWP]
Original Article 15 January 2021 Pages: 2051 - 2059
Low dose venetoclax in combination with bortezomib, daratumumab, and dexamethasone for the treatment of relapsed/refractory multiple myeloma patients—a single-center retrospective study
Bernard Regidor
Marissa-Skye Goldwater
James R. Berenson
Original Article 14 May 2021 Pages: 2061 - 2070
Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major ABO-mismatched transplants
Pallavi Mehta
Stalin Ramprakash
Lawrence Faulkner
Original Article 19 June 2021 Pages: 2071 - 2078
Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation
Aleksandra Wysocka-Słowik
Lidia Gil
Barbara Dorocka-Bobkowska
Original Article Open access 12 June 2021 Pages: 2079 - 2086
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
Patrick Derigs
Aleksandar Radujkovic
Michael Schmitt
Original Article Open access 03 December 2020 Pages: 2087 - 2093
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
Henning Schäfer
Jacqueline Blümel-Lehmann
Reinhard Marks
Original Article Open access 23 March 2021 Pages: 2095 - 2103
Eculizumab, a real-life successful treatment for refractory cold agglutinin–mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders
Laura Herbreteau
Ronan Le Calloch
Lenaïg Le Clech
Letter to the Editor 18 May 2021 Pages: 2105 - 2106
Hemolytic erythrocytosis: an amalgamated phenotype from coinherited Chuvash polycythemia and G6PD Kerala-Kalyan with acquired transient stomatocytosis
Manu Jamwal
Nabhajit Mallik
Reena Das
Letter to the Editor 08 October 2020 Pages: 2107 - 2109
Acquired elliptocytosis as presenting sign of a myelodysplastic syndrome associated with deletion of chromosome 20 and mutations in TET2, DNMT3A, and U2AF1
Christoph Robier
Gerald Hoefler
Eva Hubmann
Letter to the Editor 06 January 2021 Pages: 2111 - 2112
Paroxysmal nocturnal hemoglobinuria complicated with essential thrombocythemia harboring concomitant PIGA, CALR, and ASXL1 mutations
Haruya Okamoto
Nobuhiko Uoshima
Junya Kuroda
Letter to the Editor 25 January 2021 Pages: 2113 - 2115
Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab
Alessio Di Prima
Andrea Botticelli
Massimo Breccia
Letter to the Editor 27 August 2020 Pages: 2117 - 2119
Faggot cells in acute myeloid leukemia with t(7;11)(p15;p15) and NUP98-HOXA9 fusion
Hiroto Yanagisawa
Shuichi Mizuta
Yasufumi Masaki
Letter to the Editor 08 June 2020 Pages: 2121 - 2123
Elevated plasma hemoglobin in COVID-19–related illnesses: a critical appraisal
Nishant R. Tiwari
Nagnath K. Redewad
Vivek R. Sharma
Letter to the Editor 24 September 2020 Pages: 2125 - 2126
Plasma hemoglobin in COVID-19: authors’ reply
Guido Lancman
Bridget K. Marcellino
Kevin Troy
Letter to the Editor 06 November 2020 Pages: 2127 - 2127
Management of chronic patients during the COVID-19 pandemic: the experience of a referral center for rare hematological disorders in the hardest-hit region in Italy
Irene Motta
Alessia Marcon
Marina Baldini
Letter to the Editor 02 February 2021 Pages: 2129 - 2131
Blood and platelet transfusion from a donor with presymptomatic Covid-19
Konstantinos Liapis
Menelaos Papoutselis
Ioannis Kotsianidis
Letter to the Editor 13 November 2020 Pages: 2133 - 2134
Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy—a case report
Zhiliang Hu
Wei Chen
Yongxiang Yi
Letter to the Editor 04 June 2020 Pages: 2135 - 2137
Thrombocytopenia in COVID-19: pathophysiology matters
Eleni Gavriilaki
Ioanna Sakellari
Achilles Anagnostopoulos
Letter to the Editor 18 July 2020 Pages: 2139 - 2140
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Esther Schuler
Eva-Maria Wagner-Drouet
On behalf of the German Cooperative Transplant Study Group
Correction 23 June 2021 Pages: 2141 - 2142

Volume 100, Issue 8

Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia

Extracellular vesicles from thalassemia patients carry iron-containing ferritin and hemichrome that promote cardiac cell proliferation

Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study

δ-Hemoglobinopathies in Thailand: screening, molecular basis, genotype-phenotype interaction, and implication for prevention and control of thalassemia

Diagnosis and management of non-clonal erythrocytosis remains challenging: a single centre clinical experience

The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure

Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome—excess blasts detected by next-generation sequencing technique

Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients

Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib

Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms

Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1^T315I and BCR-ABL1^T315I-E255K

Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort

Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry

Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial

Low dose venetoclax in combination with bortezomib, daratumumab, and dexamethasone for the treatment of relapsed/refractory multiple myeloma patients—a single-center retrospective study

Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major ABO-mismatched transplants

Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation

Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data

A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT

Eculizumab, a real-life successful treatment for refractory cold agglutinin–mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders

Hemolytic erythrocytosis: an amalgamated phenotype from coinherited Chuvash polycythemia and G6PD Kerala-Kalyan with acquired transient stomatocytosis

Acquired elliptocytosis as presenting sign of a myelodysplastic syndrome associated with deletion of chromosome 20 and mutations in TET2, DNMT3A, and U2AF1

Paroxysmal nocturnal hemoglobinuria complicated with essential thrombocythemia harboring concomitant PIGA, CALR, and ASXL1 mutations

Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab

Faggot cells in acute myeloid leukemia with t(7;11)(p15;p15) and NUP98-HOXA9 fusion

Elevated plasma hemoglobin in COVID-19–related illnesses: a critical appraisal

Plasma hemoglobin in COVID-19: authors’ reply

Management of chronic patients during the COVID-19 pandemic: the experience of a referral center for rare hematological disorders in the hardest-hit region in Italy

Blood and platelet transfusion from a donor with presymptomatic Covid-19

Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy—a case report

Thrombocytopenia in COVID-19: pathophysiology matters

Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Navigation